Mutares : CV Dr. Axel Müller

	- CONVENIENCE TRANSLATION -
Dr. Axel Müller
Lahnstein, Germany
Personal information
Year of birth:	1957
Place of birth:	Koblenz
Nationality:	German

Education

Studied pharmacy with state examination, doctorate as Dr. rer. nat.

Professional career
Since 2014	Independent management consultant
2010 - 2013	Board member for Production and Development
	at STADA Arzneimittel AG, Bad Vilbel
1993 - 2010	Advising the Management Board & assumption of
	various management positions on a fee basis at
	STADA Arzneimittel AG, Bad Vilbel
1985 - 1993	Various positions in the management of STADA
	Arzneimittel AG, Bad Vilbel
1980 - 1985	Research assistant at the Chair of Pharmaceuti-
	cal Technology at Johannes Gutenberg Univer-
	sity in Mainz
Membership of statutory supervisory boards
Since 2020	Chairman of the Advisory Board of the MIP
	Pharma Group (Supervisory Board of Mellifera
	Sechsunddreißigste	Beteiligungsgesellschaft

Page 1

	mbH, Berlin, pursuant to the German Limited Lia-
	bility Companies Act (GmbHG))
Since 2019	Member of the Supervisory Board of Mutares
	Management SE, Munich (not listed)

Membership of comparable domestic and foreign supervisory bodies of commercial enterprises

None

No other significant activities

Relevant knowledge, skills and experience

Dr. Axel Müller has expertise in the areas of accounting and auditing. In the course of his professional career, Dr. Axel Müller worked for many years at STADA Arzneimittel AG, which was listed on the stock exchange and included in the MDAX at the time, in numerous management positions, in particular in the areas of strategy, M&A and operations, and was most recently responsible for production and development as a member of the Management Board for several years. In this context, he also brings many years of experience in investor relations. After several years as a Senior Advisor at Arthur D. Little, he has been an Associate Partner at Fidelio Healthcare Partners since 2018 and works as an independent management consultant. He therefore brings special knowledge and experience in the application of accounting principles and internal control and risk management systems and has special knowledge and experience in the field of auditing. Dr. Axel Müller regularly undergoes further training in these areas, particularly in the field of ESG and sustainability reporting and auditing.

Disclosures in accordance with the recommendations of the German Corporate Governance Code (GCGC)

In the opinion of the Supervisory Board, Dr. Axel Müller is to be classified as independent. In the opinion of the Supervisory Board, there are no personal or business relationships of Dr. Axel Müller with the Company, its Group companies, the executive bodies of the Company or a shareholder with a material interest in the Company that must be disclosed in accordance with recommendation C.13 GCGC.

Page 2